Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients

Cerebrovascular Diseases

Volumn 30, Issue 1, 2010, Pages 15-22

  Ueno, Yuji ^a   Shimada, Yoshiaki ^a   Tanaka, Ryota ^a   Miyamoto, Nobukazu ^a   Tanaka, Yasutaka ^a   Hattori, Nobutaka ^a   Urabe, Takao ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial septal aneurysm; Patent foramen ovale; White matter disease

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART ATRIUM SEPTUM ANEURYSM; HEART ATRIUM SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE PATIENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; WHITE MATTER;

AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FORAMEN OVALE, PATENT; HEART ANEURYSM; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 77951228209     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313439     Document Type: Article

References (44)

1. Hachinski VC, Potter P, Merskey H: Leukoaraiosis. Arch Neurol 1987; 44: 21-23.
2. Kertesz A, Polk M, Carr T: Cognition and white matter changes on magnetic resonance imaging in dementia. Arch Neurol 1990; 47: 387-391.
3. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S: Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28: 1932-1939.
4. Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund LO, Gouw A, Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bazner H, Inzitari D: White matter changes and latelife depressive symptoms: longitudinal study. Br J Psychiatry 2007; 191: 212-217.
5. Henon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D: Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001; 57: 1216-1222.
6. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28: 652-659.
7. Adachi T, Kobayashi S, Yamaguchi S: Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke. Intern Med 2002; 41: 103-108.
8. Fukuda H, Kitani M: Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 1995; 26: 1593-1597.
9. Basile AM, Pantoni L, Pracucci G, Asplund K, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D: Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (leukoaraiosis and disability in the elderly) study. Cerebrovasc Dis 2006; 21: 315-322.
10. Altaf N, Daniels L, Morgan PS, Lowe J, Gladman J, MacSweeney ST, Moody A, Auer DP: Cerebral white matter hyperintense lesions are associated with unstable carotid plaques. Eur J Vasc Endovasc Surg 2006; 31: 8-13.
11. Altaf N, Morgan PS, Moody A, MacSweeney ST, Gladman JR, Auer DP: Brain white matter hyperintensities are associated with carotid intraplaque hemorrhage. Radiology 2008; 248: 202-209.
12. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H: Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-1689.
13. Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H: Neuropathologic correlates of leuko-araiosis. Arch Neurol 1989; 46: 1124-1128.
14. Wardlaw JM, Sandercock PAG, Dennis MS, Starr J: Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34: 806-812.
15. Thompson T, Evans W: Paradoxical embolism. Q J Med 1930; 23: 135-137.
16. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20.
17. Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD, Enriquez- Sarano M, Seward JB, Covalt JL, Sicks JD, Wiebers DO: Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: The SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc 1999; 74: 862-869.
18. Silver MD, Dorsey JS: Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978; 102: 62-65.
19. Olivares-Reyes A, Chan S, Lazar EJ, Bandlamudi K, Narla V, Ong K: Atrial septal aneurysm: a new classification in two hundred five adults. J Am Soc Echocardiogr 1997; 10: 644-656.
20. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-1746.
21. Bonati LH, Kessel-Schaefer A, Linka AZ, Buser P, Wetzel SG, Radue EW, Lyrer PA, Engelter ST: Diffusion-weighted imaging in stroke attributable to patent foramen ovale: significance of concomitant atrial septum aneurysm. Stroke 2006; 37: 2030-2034.
22. Fisher CM: Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979; 36: 65-73.
23. Cacciatore A, Russo LS Jr: Lacunar infarction as an embolic complication of cardiac and arch angiography. Stroke 1991; 22: 1603-1605.
24. Ueno Y, Kimura K, Iguchi Y, Shibazaki K, Inoue T, Urabe T: Right-to-left shunt and lacunar stroke in patients without hypertension and diabetes. Neurology 2007; 68: 528-531.
25. Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Bertha G, Lechner H: White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988; 19: 1285-1288.
26. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993; 24: 35-41.
27. Ueno Y, Kimura K, Iguchi Y, Shibazaki K, Inoue T, Hattori N, Urabe T: Mobile aortic plaques are a cause of multiple brain infarcts seen on diffusion-weighted imaging. Stroke 2007; 38: 2470-2476.
28. Chamorro A, Saiz A, Vila N, Ascaso C, Blanc R, Alday M, Pujol J: Contribution of arterial blood pressure to the clinical expression of lacunar infarction. Stroke 1996; 27: 388-392.
29. Boon A, Lodder J, Heuts-van Raak L, Kessels F: Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke 1994; 25: 2384-2390.
30. Albers GW, Comess KA, DeRook FA, Bracci P, Atwood JE, Bolger A, Hotson J: Transesophageal echocardiographic findings in stroke subtypes. Stroke 1994; 25: 23-28.
31. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y: Prevalence of patent foramen ovale in patients with stroke. N Eng J Med 1988; 318: 1148-1152.
32. Moon RE, Camporesi EM, Kisslo JA: Patent foramen ovale and decompression sickness in divers. Lancet 1989; 1: 513-514.
33. Job FP, Ringelstein EB, Grafen Y, Flachskampf FA, Doherty C, Stockmanns A, Hanrath P: Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994; 74: 381-384.
34. Stone DA, Godard J, Corretti MC, Kittner SJ, Sample C, Price TR, Plotnick GD: Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996; 131: 158-161.
35. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, Whisnant JP, Wiebers DO, Covalt JL, Petterson TM, Christianson TJ, Agmon Y: Patent foramen ovale: innocent or guilty Evidence from a prospective population-based study. J Am Coll Cardiol 2006; 47: 440-445.
36. Jones EF, Calafiore P, Donnan GA, Tonkin AM: Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994; 74: 596-599.
37. Purandare N, Oude Voshaar RC, Burns A, Velupandian UM, McCollum C: Paradoxical embolization: a potential cause of cerebral damage in Alzheimer's disease? Neurol Res 2006; 28: 679-684. (Pubitemid 44433329)
38. Purandare N, Oude Voshaar RC, McCollum C, Jackson A, Burns A: Paradoxical embolisation and cerebral white matter lesions in dementia. Br J Radiol 2008; 81: 30-34.
39. Adami A, Rossato G, Cerini R, Thijs VN, Pozzi-Mucelli R, Anzola GP, Del Sette M, Finocchi C, Meneghetti G, Zanferrari C: Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology 2008; 71: 101-107.
40. Del Sette M, Dinia L, Bonzano L, Roccatagliata L, Finocchi C, Parodi RC, Sivori G, Gandolfo C: White matter lesions in migraine and right-to-left shunt: a conventional and diffusion MRI study. Cephalalgia 2008; 28: 376-382.
41. Zicari E, Tassi R, Stromillo ML, Pellegrini M, Bianchi S, Cevenini G, Gistri M, De Stefano N, Federico A, Dotti MT: Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings. Stroke 2008; 39: 2155-2157.
42. Knauth M, Ries S, Pohimann S, Kerby T, Forsting M, Daffertshofer M, Hennerici M, Sartor K: Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. BMJ 1997; 14: 701-705.
43. Gerriets T, Tetzlaff K, Hutzelmann A, Liceni T, Kopiske G, Struck N, Reuter M, Kaps M: Association between right-to-left shunt and brain lesions in sport divers. Aviat Space Environ Med 2003; 74: 1058-1060.
44. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG: Classification of stroke subtypes. Cerebrovasc Dis 2009; 27: 493-501.